Evaluation of the clinical impact of the revised Bronchodilator responsiveness of the ATS/ERS 2021 on asthmatic children
F. ELLEUCH (Sfax, Tunisia), R. Kammoun (Sfax, Tunisia), S. Sellami (Sfax, Tunisia), S. Ben Jemaa (Sfax, Tunisia), F. Gargouri (Sfax, Tunisia), I. Kammoun (Sfax, Tunisia), K. Masmoudi (Sfax, Tunisia)
Source: International Congress 2022 – Assessment of respiratory physiology
Session: Assessment of respiratory physiology
Session type: Thematic Poster
Number: 3510
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. ELLEUCH (Sfax, Tunisia), R. Kammoun (Sfax, Tunisia), S. Sellami (Sfax, Tunisia), S. Ben Jemaa (Sfax, Tunisia), F. Gargouri (Sfax, Tunisia), I. Kammoun (Sfax, Tunisia), K. Masmoudi (Sfax, Tunisia). Evaluation of the clinical impact of the revised Bronchodilator responsiveness of the ATS/ERS 2021 on asthmatic children. 3510
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|